Clinical trial
Personalized Therapy of Cystic Fibrosis: Set-up of Response Markers
NCT02965326 is registered in ClinicalTrials.gov with Hôpital Necker-Enfants Malades as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Personalized Therapy of Cystic Fibrosis: Set-up of Response Markers
- Lead sponsor
- Hôpital Necker-Enfants Malades
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- May 31, 2016
- Completion date
- October 31, 2026
- Enrollment
- 75 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.